Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment
CompanyDeals

Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment

Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone
CompanyDeals

Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone

EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research
Company

EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research

China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
Medical DevicePolicy / Regulatory

China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled

Policy Analysis: Shanghai's 2025 Pharmaceutical Procurement Regulation and Market Implications
Policy / Regulatory

Policy Analysis: Shanghai’s 2025 Pharmaceutical Procurement Regulation and Market Implications

Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics
Policy / Regulatory

Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics

China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control
Medical DevicePolicy / Regulatory

China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma
CompanyDeals

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma

Sinovac Biotech's SNA02-48 Granted Clinical Approval for Tetanus Prevention
CompanyDrug

Sinovac Biotech’s SNA02-48 Gains Clinical Approval for Tetanus Prevention

Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement
Policy / Regulatory

Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement

Abbott Laboratories' Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment
CompanyMedical Device

Abbott Laboratories’ Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy
CompanyDeals

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy